Impact of pacemaker longevity on expected device replacement rates: Results from computer simulations based on a multicenter registry (ESSENTIAL). Issue 9 (22nd September 2018)

• Record Type: Journal Article
• Authors: Boriani, Giuseppe; Bertini, Matteo; Saporito, Davide; Belotti, Giuseppina; Quartieri, Fabio; Tomasi, Corrado; Pucci, Angelo; Boggian, Giulio; Mazzocca, Gian Franco; Giorgi, Davide; Diotallevi, Paolo; Sassone, Biagio; Grassini, Diego; Gargaro, Alessio; Biffi, Mauro
• Is Part Of: Clinical cardiology. Volume 41:Issue 9(2018)
• Page Start: 1185
• Page End: 1191
• Publication Date: 2018-09-22
• Subjects: complications -- computer simulation -- life expectancy -- pacemaker longevity; Cardiology -- Periodicals; 616.12005
• DOI: 10.1002/clc.23003
• Languages: English
• ISSNs: 0160-9289

Abstract

Abstract : Background: The rate of device replacement in pacemaker recipients has not been investigated in detail. Hypothesis: Current pacemakers with automatic management of atrial and ventricular pacing output provide sufficient longevity to minimize replacement rate. Methods: We considered a cohort of 542 pacemaker patients (age 78 ± 9 years, 60% male, 71% de‐novo implants) and combined 1‐month projected device longevity with survival data and late complication rate in a 3‐state Markov model tested in several Monte Carlo computer simulations. Predetermined subgroups were: age < or ≥ 70; gender; primary indication to cardiac pacing. Results: At the 1‐month follow‐up the reported projected device longevity was 153 ± 45 months. With these values the proportion of patients expected to undergo a device replacement due to battery depletion was higher in patients aged <70 (49.9%, range 32.1%‐61.9%) than in age ≥70 (24.5%, range 19.9%‐28.8%); in women (39.9%, range 30.8%‐48.1%) than in men (32.0%, range 24.7%‐37.5%); in sinus node dysfunction (41.5%, range 30.2%‐53.0%) than in atrio‐ventricular block (33.5%, range 27.1‐38.8%) or atrial fibrillation with bradycardia (27.9%, range 18.5%‐37.0%). The expected replacement rate was inversely related to the assumed device longevity and depended on age class: a 50% increase in battery longevity implied a 5% reduction of replacement rates in patients aged ≥80. Conclusions: With current device technology 1/4 of pacemaker recipients aged ≥70 are expected to receive a second device in their life. Replacement rate depends on age, gender, and primary indication owing to differences in patients' survival expectancy. Additional improvements in device service time may modestly impact expected replacement rates especially in patients ≥80 years.